Crown Bioscience announced the extension of its partnership with NEXT Oncology to leverage Crown Bioscience’s extensive experience in developing clinically relevant cancer organoid and patient-derived xenograft models, together with NEXT Oncology’s global clinical network and Phase I clinical trials expertise.
[Crown Bioscience]
